HCP (HCP) — Earnings Call X-Ray
Our AI read all 25 of HCP's earnings calls (2016–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
D
Q3 2024
Calls Analyzed
25
2016–2024
Avg Candor
7/9
evasion 3.1/9
Call-by-call analysis
🔒 Q4 2024 earnings call
2024-03-05
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q4 2024 call grade is ready
The full 37-point AI read of HCP's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
D
Q3 2024 earnings call
2023-12-07
move ±23.6%
Management held guidance steady against slowing demand and expanding margins.
Guidance: maintainedDemand: slowingMargins: expandingBacklog: growingPricing: stable 16 analysts · 23 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Prepayments growing⚑ Reads rehearsedFounder-led
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q2 2024 earnings call
2023-08-31
move ±12.6%
Management held guidance steady against slowing demand and expanding margins.
Guidance: maintainedDemand: slowingMargins: expandingBacklog: growingPricing: stableHeadcount: cutting 12 analysts · 18 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
F
Q1 2024 earnings call
2023-06-07
move ±29.9%
Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid.
Guidance: loweredDemand: slowingMargins: expandingBacklog: growingPricing: under pressureHeadcount: cutting 13 analysts · 19 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Prepayments growing✓ Early product, fast growthFounder-led
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q4 2022 earnings call
2023-03-09
move ±16.2%
Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: maintainedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growing 13 analysts · 21 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B+
Q3 2023 earnings call
2022-12-07
move ±21.6%
Management raised guidance against mixed demand signals and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: raisedDemand: mixedMargins: expandingBacklog: growingPricing: stableHeadcount: flat 15 analysts · 28 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
A
Q2 2023 earnings call
2022-09-01
move ±12.3%
Management raised guidance against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growing 12 analysts · 23 questions
✓ Clean call✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
NO Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
B
Q1 2023 earnings call
2022-06-02
move ±34.7%
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics.
Guidance: raisedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growing 13 analysts · 22 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Prepayments growing✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q4 2022 |
2022-03-10 |
C+ |
none | accelerating | stable |
6/9 |
3/9 |
| Q3 2019 |
2019-11-01 |
B |
raised | mixed | stable |
7/9 |
3/9 |
| Q2 2019 |
2019-08-01 |
B+ |
raised | accelerating | expanding |
7/9 |
2/9 |
| Q1 2019 |
2019-05-02 |
C+ |
maintained | mixed | unclear |
7/9 |
4/9 |
| Q4 2018 |
2019-02-14 |
C+ |
maintained | mixed | contracting |
8/9 |
2/9 |
| Q3 2018 |
2018-10-31 |
B+ |
maintained | mixed | contracting |
8/9 |
1/9 |
| Q2 2018 |
2018-08-02 |
B+ |
raised | mixed | contracting |
8/9 |
3/9 |
| Q1 2018 |
2018-05-03 |
C+ |
maintained | mixed | contracting |
7/9 |
3/9 |
| Q4 2017 |
2018-02-13 |
D |
lowered | mixed | contracting |
7/9 |
3/9 |
| Q3 2017 |
2017-11-02 |
B |
raised | mixed | stable |
7/9 |
2/9 |
| Q2 2017 |
2017-08-01 |
F |
maintained | slowing | contracting |
6/9 |
5/9 |
| Q1 2017 |
2017-05-02 |
C+ |
maintained | mixed | stable |
7/9 |
3/9 |
| Q4 2016 |
2017-02-13 |
C+ |
maintained | mixed | contracting |
7/9 |
2/9 |
| Q3 2016 |
2016-11-01 |
C |
lowered | mixed | stable |
8/9 |
2/9 |
| Q2 2016 |
2016-08-09 |
C+ |
raised | stable | stable |
7/9 |
5/9 |
| Q1 2016 |
2016-05-09 |
D |
raised | mixed | stable |
7/9 |
5/9 |
| Q4 2015 |
2016-02-09 |
F |
lowered | slowing | contracting |
6/9 |
5/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of HCP's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
F
Q2 2017 earnings call
2017-08-01
8 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← HCOM All “H” companies
HCR →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.